Search

Your search keyword '"Min-Chi Li"' showing total 3 results
Start Over Author "Min-Chi Li" Database OpenAIRE
3 results on '"Min-Chi Li"'

1. Anosmia and olfactory tract neuropathy in a case of COVID-19

Author

Ling Shan Syue, Nan Yao Lee, Po Lin Chen, Chin Shiang Tsai, Chia Wen Li, Min Chi Li, Ching Lung Lo, Yi Shan Tsai, and Wen Chien Ko

Subjects
Male, 0301 basic medicine, Microbiology (medical), Pathology, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Anosmia, 030106 microbiology, lcsh:QR1-502, Antibodies, Viral, medicine.disease_cause, lcsh:Microbiology, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Immunology and Allergy, Brain magnetic resonance imaging, 030212 general & internal medicine, Pandemics, Coronavirus, General Immunology and Microbiology, SARS-CoV-2, business.industry, COVID-19, General Medicine, Magnetic Resonance Imaging, Olfactory Bulb, Infectious Diseases, medicine.symptom, Ageusia, business, Olfactory tract
Abstract

Coronavirus Disease-19 (COVID-19) has been in a global pandemic currently and relating symptoms were reported variously around the world. We reported a previously healthy man of COVID-19 presenting with anosmia as the obvious symptom with relevant radiological findings on brain magnetic resonance imaging.

Published
2021
Full Text
View/download PDF

2. Pancreaticobiliary Cancers and Aeromonas Isolates Carrying Type Ⅲ Secretion System Genes ascF-ascG Are Associated With Increased Mortality: An Analysis of 164 Aeromonas Infection Episodes in Southern Taiwan

Author

Ying-Wen Chen, Shu-Li Su, Chia-Wen Li, Chin-Shiang Tsai, Ching-Lung Lo, Ling-Shan Syue, Min-Chi Li, Ching-Chi Lee, Nan-Yao Lee, Wen-Chien Ko, and Po-Lin Chen

Subjects
Microbiology (medical), Cefotaxime, Cefepime, Immunology, ascF-ascG, Tigecycline, Microbiology, type 3 secretion system, chemistry.chemical_compound, medicine, rpoD sequencing, antimicrobial resistance, biology, business.industry, Aeromonas infection, biology.organism_classification, medicine.disease, QR1-502, Infectious Diseases, Aeromonas, chemistry, Bacteremia, identification, business, Ertapenem, medicine.drug, Aeromonas veronii
Abstract

This prospective study aimed to investigate the clinical and microbiological characteristics of different Aeromonas species. Clinical isolates of Aeromonas species between 2016 to 2018 were collected in a university hospital in southern Taiwan. The species was determined by rpoD or gyrB sequencing. A total of 222 Aeromonas isolates from 160 patients in 164 episodes were identified. The crude in-hospital mortality was 17.2%. The most frequently isolated species was Aeromonas veronii (30.6%), followed by A. caviae (24.8%), A. hydrophila (23%), and A. dhakensis (16.7%). The major clinical manifestations were primary bacteremia (31.1%), skin and soft tissue infection (22.6%), and biliary tract infection (18.3%). The most common underlying diseases were malignancy (45.1%), diabetes mellitus (27.4%), and liver cirrhosis or chronic hepatitis (26.2%). A. hydrophila and A. dhakensis predominated in the skin and soft tissue infection (pA. vernoii and A. caviae prevailed in primary bacteremia and biliary tract infections (p=0.012). Pneumonia, malignancy, and ascF-ascG genotype were independent factors associated with mortality. Ertapenem susceptibility was decreased in A. sobria (42.9%), A. veronii (66.7%), A. dhakensis (73%), and A. hydrophila (84.3%). Cefotaxime resistance was found in 30.9% of A. caviae and 18.9% of A. dhakensis isolates, much more prevalent than the other species. The metallo-β-lactamase blaCphA was almost invariably present in A. dhakensis, A. hydrophila, and A. veronii (100%, 100% and 89.9%, respectively). Amp-C β-lactamases such as blaMOX and blaAQU-1 were identified in all A. caviae and 91.9% of A. dhakensis isolates. Cefepime, fluoroquinolones and tigecycline showed good in vitro activity against aeromonads.

Published
2021
Full Text
View/download PDF

3. Pancreaticobiliary Cancers and Aeromonas Isolates Carrying Type Ⅲ Secretion System Genes

Author

Ying-Wen, Chen, Shu-Li, Su, Chia-Wen, Li, Chin-Shiang, Tsai, Ching-Lung, Lo, Ling-Shan, Syue, Min-Chi, Li, Ching-Chi, Lee, Nan-Yao, Lee, Wen-Chien, Ko, and Po-Lin, Chen

Subjects
Taiwan, pancreaticobiliary cancers, ascF-ascG, Anti-Bacterial Agents, type 3 secretion system, virulence, Cellular and Infection Microbiology, Neoplasms, Type III Secretion Systems, rpoD sequencing, Humans, identification, Aeromonas, Prospective Studies, antimicrobial resistance, Gram-Negative Bacterial Infections, Original Research
Abstract

This prospective study aimed to investigate the clinical and microbiological characteristics of different Aeromonas species. Clinical isolates of Aeromonas species between 2016 to 2018 were collected in a university hospital in southern Taiwan. The species was determined by rpoD or gyrB sequencing. A total of 222 Aeromonas isolates from 160 patients in 164 episodes were identified. The crude in-hospital mortality was 17.2%. The most frequently isolated species was Aeromonas veronii (30.6%), followed by A. caviae (24.8%), A. hydrophila (23%), and A. dhakensis (16.7%). The major clinical manifestations were primary bacteremia (31.1%), skin and soft tissue infection (22.6%), and biliary tract infection (18.3%). The most common underlying diseases were malignancy (45.1%), diabetes mellitus (27.4%), and liver cirrhosis or chronic hepatitis (26.2%). A. hydrophila and A. dhakensis predominated in the skin and soft tissue infection (p

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results